Register for our free email digests:
Eli Lilly & Co.
www.lilly.com
Latest From Eli Lilly & Co.
Dual Approval For Verzenio Under International Review Scheme
The joint review by Australia and Canada of the metastatic breast cancer drug, Verzenio, helped regulators in both jurisdictions achieve efficiencies.
BI Bets On Expanding Jardiance As Diabetes Drug Sales Soar
The German major believes its drug will remain the biggest-selling SGLT-2 inhibitor boosted by expanded heart and renal disease approvals.
J&J's Spravato's Star Power Rises While Zytiga's Sets
With Spravato's launch underway, J&J reports that 800 sites have been certified to administer the depression drug. Newer drugs drove pharma sales in the first quarter, while US sales of Zytiga declined 55% due to generic competition.
What Will Happen When Rebates Go Away? Look At Authorized Generics
Recent launches by Lilly, Amgen and Gilead suggest list prices may decrease with the HHS proposal to disrupt the rebate system, but not as low as current net prices after rebates, according to pharmacy benefit experts.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Eli Lilly & Co.
- Alnara Pharmaceuticals Inc.
- Applied Molecular Evolution Inc.
- Armo BioSciences Inc.
- Avid Radiopharmaceuticals Inc.
- Chorus
- Chugai Lilly Clinical Research Co. Ltd.
- CoLucid Pharmaceuticals Inc.
- Eli Lilly & Co. (India) Pvt. Ltd.
- Eli Lilly Canada Inc.
- Eli Lilly Deutschland GMBH
- Eli Lilly Japan
- Eli Lilly Ranbaxy Ltd.
- Eli Lilly Suzhou Pharmaceutical Group Co. Ltd.
- Hypnion Inc.
- Icos Corp.
- ImClone Systems Inc.
- InnoCentive LLC
- Lilly Research Centre Ltd.
- Lilly Research Laboratories
- Loxo Oncology Inc.
- Medical Devices & Diagnostics
- Pacific Biotech Inc.
- SGX Pharmaceuticals Inc.
- Senior Management
-
David Ricks, CEO
Joshua L Smiley, SVP, CFO
Daniel M Skovronsky, MD, PhD, SVP, CSO - Contact Info
-
Eli Lilly & Co.
Phone: (317) 276-2000
Lilly Corporate Ctr.
Indianapolis, IN 46285
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice